Cardioversión en FA/Flutter: manejo antitrombótico
FA presentación
FA < 48 h.
FA > 48 h.
FA tiempo desconocido
Estabilidad Hemodinamica
HDMC Estable
HDMC Inestable
ECO transesofagico
ECO NO disponible
Trombos (-)
Trombos (+)
Riesgo Tromboembolico
CHA²DS²VASc > 0
Bajo Riesgo
Calcular
Cerrar
Recomendación terapéutica
ACO
: Dabigatran, Rivaroxaban, Apixaban
VKA
: Vitamina K antagonistas
Cardioversión recomendaciones
Riesgo tromboembolico
CHA²DS²-VASc Score
R.Pitarch
©©
2014
Adaptado de:
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) 2010:
Guidelines for the management of atrial fibrillation
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation